Presence of valine at position 27 of the hepatitis B virus core gene is associated with severe liver inflammation in Chinese patients

Journal of Medical Virology

Volumn 83, Issue 2, 2011, Pages 218-224

  Yang, Ling ^a   Ma, Shiwu ^a,b   Hu, Xiaoxiong ^a   Xiao, Lei ^a   Wang, Zhanhui ^a   Li, Yongyin ^a   Zhou, Bin ^a   Abbott, William G H ^a,c   Hou, Jinlin ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

^b KUNMING GENERAL HOSPITAL   (China)

^c AUCKLAND CITY HOSPITAL   (New Zealand)

Author keywords

Acute on chronic liver failure; CD8; Chronic hepatitis B; Cytotoxic T cell; HLA

Indexed keywords

HEPATITIS B CORE ANTIGEN; HLA A2 ANTIGEN; VALINE;

ADULT; AMINO ACID SUBSTITUTION; ANTIGEN BINDING; ANTIGEN RECOGNITION; ARTICLE; CD8+ T LYMPHOCYTE; CHINESE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DISEASE SEVERITY; FEMALE; FOLLOW UP; GENE FREQUENCY; GENOTYPE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; HUMAN CELL; LIVER FAILURE; MAJOR CLINICAL STUDY; MALE; MEMORY CELL; MORTALITY; NONHUMAN; VIRUS GENE; VIRUS MUTATION; VIRUS PATHOGENESIS; WILD TYPE;

ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; CD8-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; FEMALE; GENE FREQUENCY; HEPATITIS B CORE ANTIGENS; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HLA-A ANTIGENS; HOST-PATHOGEN INTERACTIONS; HUMANS; MALE; MUTATION; SEVERITY OF ILLNESS INDEX; T-LYMPHOCYTES, CYTOTOXIC; VALINE;

HEPATITIS B VIRUS;

EID: 78650313734     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.21944     Document Type: Article

References (18)

1. Abbott WG, Tsai P, Leung E, Trevarton A, Ofanoa M, Hornell J, Gane EJ, Munn SR, Rodrigo AG. 2010. Associations between HLA class I alleles and escape mutations in the hepatitis B virus core gene in New Zealand-resident Tongans. J Virol 84: 621-629.
2. Allain JP. 2006. Epidemiology of hepatitis B virus and genotype. J Clin Virol 36: S12-S17.
3. Bertoletti A, Chisari FV, Penna A, Guilhot S, Galati L, Missale G, Fowler P, Schlicht HJ, Vitiello A, Chesnut RC, Fiaccadori F, Ferrari C. 1993. Definition of a minimal optimal cytotoxic T-cell epitope within the hepatitis B virus nucleocapsid protein. J Virol 67: 2376-2380.
4. Bertoletti A, Costanzo A, Chisari FV, Levrero M, Artini M, Sette A, Penna A, Giuberti T, Fiaccadori F, Ferrari C. 1994. Cytotoxic T lymphocyte response to a wild type hepatitis B virus epitope in patients chronically infected by variant viruses carrying substitutions within the epitope. J Exp Med 180: 933-943.
5. Ehata T, Omata M, Chuang WL, Yokosuka O, Ito Y, Hosoda K, Ohto M. 1993. Mutations in core nucleotide sequence of hepatitis B virus correlate with fulminant and severe hepatitis. J Clin Invest 91: 1206-1213.
6. Guidotti LG. 2002. The role of cytotoxic T cells and cytokines in the control of hepatitis B virus infection. Vaccine 20: A80-A82.
7. Gunther S. 2006. Genetic variation in HBV infection: Genotypes and mutants. J Clin Virol 36: S3-S11.
8. Imamura T, Yokosuka O, Kurihara T, Kanda T, Fukai K, Imazeki F, Saisho H. 2003. Distribution of hepatitis B viral genotypes and mutations in the core promoter and precore regions in acute forms of liver disease in patients from Chiba, Japan. Gut 52: 1630-1637.
9. Liaw YF. 2003. Hepatitis flares and hepatitis B e antigen seroconversion: Implication in anti-hepatitis B virus therapy. J Gastroenterol Hepatol 18: 246-252.
10. Lindh M, Andersson AS, Gusdal A. 1997. Genotypes, nt 1858 variants, and geographic origin of hepatitis B virus-Large-scale analysis using a new genotyping method. J Infect Dis 175: 1285-1293.
11. Liu CJ, Chen PJ, Lai MY, Kao JH, Chang CF, Wu HL, Shau WY, Chen DS. 2003. A prospective study characterizing full-length hepatitis B virus genomes during acute exacerbation. Gastroenterology 124: 80-90.
12. Liu HG, Chen WW, Fan ZP, Yang HY, Shi M, Zhang Z, Luan SS, Zhang H, Lu P, Tien P, Wang FS. 2007. The high prevalence of the I27 mutant HBcAg18-27 epitope in Chinese HBV-infected patients and its cross-reactivity with the V27 prototype epitope. Clin Immunol 125: 337-345.
13. Ma SW, Liang MF, Yu YC, Wang ZH, Zhou B, Hou JL. 2008. Characteristics of HBcAg(18-27) CTL epitopes of the main epidemic HBV strains in China. Zhonghua Gan Zang Bing Za Zhi 16: 93-96.
14. Maini MK, Boni C, Lee CK, Larrubia JR, Reignat S, Ogg GS, King AS, Herberg J, Gilson R, Alisa A, Williams R, Vergani D, Naoumov NV, Ferrari C, Bertoletti A. 2000. The role of virus-specific CD8(+) cells in liver damage and viral control during persistent hepatitis B virus infection. J Exp Med 191: 1269-1280.
15. Reignat S, Webster GJ, Brown D, Ogg GS, King A, Seneviratne SL, Dusheiko G, Williams R, Maini MK, Bertoletti A. 2002. Escaping high viral load exhaustion: CD8 cells with altered tetramer binding in chronic hepatitis B virus infection. J Exp Med 195: 1089-1101.
16. Sarin SK, Kumar A, Almeida JA, Chawla YK, Fan ST, Garg H, de Silva HJ, Hamid SS, Jalan R, Komolmit P, Lau GK, Liu Q, Madan K, Mohamed R, Ning Q, Rahman S, Rastogi A, Riordan SM, Sakhuja P, Samuel D, Shah S, Sharma BC, Sharma P, Takikawa Y, Thapa BR, Wai CT, Yuen MF. 2009. Acute-on-chronic liver failure: Consensus recommendations of the Asian Pacific Association for the study of the liver (APASL). Hepatol Int 3: 269-282.
17. Tan AT, Koh S, Goh W, Zhe HY, Gehring AJ, Lim SG, Bertoletti A. 2010. A longitudinal analysis of innate and adaptive immune profile during hepatic flares in chronic hepatitis B. J Hepatol 52: 330-339.
18. Zeng G, Wang Z, Wen S, Jiang J, Wang L, Cheng J, Tan D, Xiao F, Ma S, Li W, Luo K, Naoumov NV, Hou J. 2005. Geographic distribution, virologic and clinical characteristics of hepatitis B virus genotypes in China. J Viral Hepat 12: 609-617.